Chemotherapy breakthrough? study halted early for esophageal cancer
NCT ID NCT03301454
First seen Mar 22, 2026 · Last updated May 12, 2026 · Updated 9 times
Summary
This study aimed to find out if patients with metastatic esophageal cancer who were not getting worse after 6 weeks of chemotherapy should continue treatment or stop. Only 15 people took part before the study was ended early. The goal was to see if continuing chemo helped patients live longer or slowed the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER, SQUAMOUS CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre François Baclesse
Caen, 14076, France
-
Centre Hospitalier de Boulogne sur mer
Boulogne-sur-Mer, 62200, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre René Gauducheau
Nantes, 44805, France
-
Hôpital Privé Arras Les Bonnettes
Arras, 62000, France
Conditions
Explore the condition pages connected to this study.